Interim safety analysis of cancer immunotherapy trials Network - 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer

• Main Authors: T.S. Uldrick (Author), M.A. 'Mac' Cheever (Author), P.H. Gonçalves (Author), S. Fling (Author), K. Aleman (Author), B. Emu (Author), M.S. Ernstoff (Author), R. Gorelick (Author), J. Kaiser (Author), H. E Kohrt (Author), A. Lacroix (Author), M. Lindsley (Author), L. M Lundgren (Author), K. Lurain (Author), F. Maldarelli (Author), C. Parsons (Author), E. Sharon (Author), A. Widell (Author), R. Yarchoan (Author)
• Format: Book
• Published: Elsevier, 2017-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.